Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
08/2010
08/19/2010CA2750991A1 Control of plant stress tolerance, water use efficiency and gene expression using novel aba receptor proteins and synthetic agonists
08/19/2010CA2749392A1 Rbm3 protein in colorectal cancer prognostics
08/19/2010CA2726230A1 The stabilisation of proteins
08/18/2010EP2218789A1 Process for the production of L-amino acids using coryneform bacteria
08/18/2010EP2218783A1 Novel method for the manufacturing of neurotoxins
08/18/2010EP2218775A1 Method for producing a polypeptide in vitro in mammalian cells in a protein-free and serum-free culture medium
08/18/2010EP2218736A1 Implant coated with multi-domain amphipathic helical peptides and methods of their use
08/18/2010EP2218735A1 Diagnostic and therapeutic use of Kremen 1 and 2, inhibitors of the canonical Wnt-signaltransduction
08/18/2010EP2218734A2 Glucagon-like peptide-2 analogs
08/18/2010EP2218733A1 Compounds and methods for treatment and diagnosis of chlamydial infection
08/18/2010EP2218732A1 Chlamydia trachomatis genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection
08/18/2010EP2218731A1 Chlamydia trachomatis genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection
08/18/2010EP2218730A1 Chlamydia trachomatis genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection
08/18/2010EP2218729A1 An L-amino acid-producing bacterium and a method for producing an L-amino acid
08/18/2010EP2218458A1 Molecules able to modulate the expression of at least a gene involved in degradative pathways and uses thereof
08/18/2010EP2217730A1 Methods for assaying mc1r variants and mitochondrial markers in skin samples
08/18/2010EP2217697A1 Use of lingo-4 antagonists in the treatment of conditions involving demyelination
08/18/2010EP2217626A1 Epitope for neutralizing antibodies
08/18/2010EP2217623A2 T-cell receptor peptides specific for part of cd20 , uses thereof, and methods of preparing cytotoxic t-cells
08/18/2010EP2217622A2 Method for the separation of cells
08/18/2010EP2217621A1 Insulin derivative
08/18/2010EP2217620A2 Variants of c-type natriuretic peptide
08/18/2010EP2217619A1 Cyclic, cystein-free protein
08/18/2010EP2217618A2 Novel marker genes for regulatory t cells from human blood
08/18/2010EP2217617A1 Compositions for detecting antibodies to babesia microti and methods of uses thereof
08/18/2010EP2217616A1 Methods for generating marker free transgenic plants
08/18/2010EP2217271A1 Mycoplasma hyopneumoniae avirulent -adjuvanted live vaccine
08/18/2010EP2217264A2 Methods for the treatment of radiation or chemotherapy-induced tissue damage
08/18/2010EP2217262A2 C-terminal ifapsoriasin fragments as antimicrobial peptides, the production thereof and use thereof
08/18/2010EP2217249A1 Inhibition of versican with sirna and other molecules
08/18/2010EP2058329B1 Improved secretion of neublastin
08/18/2010EP1767633B1 Novel polypeptide useful for diagnosis and treatment of cancer
08/18/2010EP1626983B1 Novel poly (ethylene glycol) modified erythropoietin agonists and uses thereof
08/18/2010EP1597275B1 Use of the Chlamydia pneumoniae CPn0104 polypeptide or antibodies thereto to diagnose Chlamydia infections
08/18/2010EP1461360B1 Conjugates comprising an antibody specific for the ed-b domain of fibronectin and their use for the detection and treatment of tumours
08/18/2010EP1417222B1 Isolated polypeptides based on the neutralizing epitope of the p17 protein of hiv useful as vaccines, and neutralizing anti-p17 antibodies which specifically recognize said neutralizing epitope
08/18/2010EP1307222B1 Non-human animal models of tolerance to hepatitis c virus immunogens
08/18/2010EP0723402B1 Senescent cell-derived inhibitors of dna synthesis
08/18/2010CN1729018B G-CSF conjugates
08/18/2010CN1724567B Stable recombination human interferon alpha 1b water solution
08/18/2010CN1704121B Anti-angiogenic compositions and methods of use
08/18/2010CN101809155A Transgenic plants with increased stress tolerance and yield
08/18/2010CN101809153A Factor involved in latent infection with herpesvirus, and use thereof
08/18/2010CN101809152A Fluorescent protein with deep blue color
08/18/2010CN101809147A Modified xylan production
08/18/2010CN101809146A Hydrocarbon-producing genes and methods of their use
08/18/2010CN101809143A Metabolically engineered escherichia coli for enchanced production of sialic acid
08/18/2010CN101809032A Method for selectively modifying a protein
08/18/2010CN101809031A Ligand binding domains of nuclear receptors in controllable form and methods involving the same
08/18/2010CN101809030A Thiopeptide precursor protein, gene encoding it and uses thereof
08/18/2010CN101809029A Peptide capable of extending half-life of peptide of interest in plasma
08/18/2010CN101808731A Immobilisation of chelating groups for immobilised metal ion chromatography (imac)
08/18/2010CN101808668A Active targeting type polymeric micelle carrying drug enclosed therein and medicinal composition
08/18/2010CN101808662A Composition and method for treatment of autoimmune disease
08/18/2010CN101808658A Cell-penetrating peptides and use thereof bonded to biomolecules with therapeutic action
08/18/2010CN101808655A Peptides derived from plasminogen activator inhibitor-1 and uses thereof
08/18/2010CN101806803A Use of complex forms of the calmodulin-like skin protein CLSP
08/18/2010CN101806800A Indirect ELISA method for detecting duck circovirus antibody
08/18/2010CN101805774A Method for comprehensively extracting oat polypeptide and oat glucan
08/18/2010CN101805773A Method for producing egg membrane protein
08/18/2010CN101805742A Vitreoscilla hemoglobin vgbS nucleotide sequence and plasmid and preparation method thereof
08/18/2010CN101805741A Male sterility gene TCL, coded protein and promoter, plasmid and host cell
08/18/2010CN101805739A Identification method of PPARD major gene, establishment of molecular breeding method and application thereof
08/18/2010CN101805738A Peculiar p53 mutated protein-p53N236S of ALT tumor caused by progeria syndrome and application thereof
08/18/2010CN101805404A Recombinant large-tooth flounder interleukin-6 protein and preparation method thereof
08/18/2010CN101805403A aurification method of prokaryotic expression Arresten protein
08/18/2010CN101805402A Anti-opioid peptide active fragment
08/18/2010CN101805401A Plant stress tolerance related protein TaHSP90-1 and coding gene and application thereof
08/18/2010CN101805400A Protein related to abscission of plant organs and coding gene and application thereof
08/18/2010CN101805399A Protein associated with thousand grain weight of wheat and encoding gene and application thereof
08/18/2010CN101805398A Gene related to plant cold resistance and disease resistance as well as encoding protein and application thereof
08/18/2010CN101805397A Mycobacterium tuberculosis ESAT-6 recombinant dipolymer, preparation method and application thereof
08/18/2010CN101805396A Anti-opioid peptide antagonist peptide and use thereof
08/18/2010CN101805395A Polypeptide with inhibiting virus mixed infection activity
08/18/2010CN101805393A REPLIKIN peptides and uses thereof
08/18/2010CN101372692B Ice flower low temperature stress transcription factor AaCBF gene sequence, and clone and use thereof
08/18/2010CN101280307B Preparation of drosophila melanogaster antibacterial peptide diptericin
08/18/2010CN101173287B Clone and application of a gene improving rice drought tolerance and relative with ABA synthesis
08/18/2010CN101117351B Method for purifying restructuring lactoferrin from transgenic cow's milk
08/17/2010US7777100 DNA sequences from tcd genomic region of Photorhabdus luminescens
08/17/2010US7777097 producing plants with increased resistance to pathogen infection by expressing disease resistance genes in the plants and transgenic plants having enhanced pathogen resistance
08/17/2010US7777020 Nucleotide sequences derived from the env gene of HIV-1
08/17/2010US7777011 A preferred synthetic polypeptide having at least one antigenic site of a prion protein which only exist in nervous tissue of a mammal suffering from spongiform encephalopathy
08/17/2010US7777007 For stimulating release of tumor necrosis factor, and/or cellular proliferation/differentiation of chondrocytes by contacting blood with pro-polypeptides; cancer diagnosis
08/17/2010US7777006 Suspension Cohn protein; adding reducing agent; precipitation; immobilization
08/17/2010US7777005 tubulin; inhibitor of cell proliferation; for drug screening
08/17/2010US7777003 Receptor polypeptides deficient in B cell epitope, in which two or more T cell epitopes are fused; immunomodulator without side effects
08/17/2010US7777001 From Vibrio cholerae phage; cadherins; immunogens; drug screening; for treatment of autoimmune and gastrointestinal diseases, food allergies, and Celiac disease; vaccines; antibodies
08/17/2010US7777000 Anti-viral activity of cathelicidin peptides
08/17/2010US7776825 Mutant polypeptides of fibroblast growth factor 1
08/17/2010US7776823 antiinflammatories, antiviral agents; coadministering with antibiotic; surface decontamination
08/17/2010US7776819 Covalently conjugating a modified peptide to a PEGylated lipid to form a conjugate; inserting the conjugate into a carrier for the compound wherein the carrier has surface ligands specific for opioid receptor; repair-specific delivery of analgesics and/or alleviate side effects associated with opioids
08/17/2010US7776817 coadministering tissue plasminogen activator, serum albumin, antidote, anticonvulsant; for damage caused by stroke, inflammation or organophosphate neurotoxins
08/17/2010US7776816 by prophylactically administering Stromal Derived Factor 1 Alpha before hypoxia induces cell death; cell-free
08/17/2010US7776620 Hapten-carrier conjugates for treating and preventing nicotine addiction
08/17/2010US7776607 determining a human subject's susceptibility to developing colon or head and neck cancer by determining a genotype of a mammalian 15 kDa selenoprotein gene; selenium containing protein for use in diagnosis, prevention and treatment prostate cell proliferative disorders
08/17/2010US7776598 Methods and compositions for polypeptide engineering
08/17/2010US7776581 producing an isolated polynucleotide sequence encoding chymosin which is modified so as to comprise at least one N X-T-glycosylation site and a method for producing such a polypeptide; milk clotting; cheesemaking
08/17/2010US7776577 drug screening; used to identify compounds that act as agonists and antagonists and modulate the expression of the novel PGP synthase
08/17/2010US7776564 Stromal cell-derived factor-1 polypeptides, polynucleotides, modulators thereof and methods of use